Mr. Cruz (for himself and Mr. Lee) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025. S. 3081. 119th
Cong., 1st
sess., Introduced in Senate October 30, 2025. https://www.govinfo.gov/app/details/BILLS-119s3081is.
APA
Congress, Senate (2025, October 30). Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025 (S. 3081 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s3081is.
MLA
United States, Congress, Senate. Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s3081is. 119th Congress, S. 3081, Introduced in Senate 30 Oct. 2025.
Bluebook
S.3081 - 119th Congress (2025-2026): Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025, S.3081, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s3081is.
